Business Description
HUTCHMED (China) Limited is a Hong Kong-based biopharmaceutical company founded in 2000 that researches and brings to market treatments for cancer and immune system disorders across global markets. The company has built a broad portfolio of drug candidates targeting a wide range of conditions, including colorectal cancer, lung cancer, leukemia, and autoimmune blood disorders, with several products already approved and others advancing through clinical trials. HUTCHMED works alongside major pharmaceutical partners such as AstraZeneca, Lilly, and Takeda to accelerate the development and distribution of its medicines.
